HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE. - Test2 - elhamkhani - TriplyDB

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

http://www.wikidata.org/entity/Q37279897

about

Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy.

P2860

Q39041123-737EF583-F20A-4223-B501-EEE76E174C2B

P2860

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

http://www.wikidata.org/entity/Q37279897

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@en

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@nl

type

label

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@en

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@nl

prefLabel

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@en

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@nl

P1433

Q37279897-9ECA8A41-0B40-44C5-A2FC-1A564180BC15

P1476

Q37279897-746A76DA-36C3-42F7-840A-006EDBC54EEF

P2093

Q37279897-119D1A81-AC7B-4A95-AA64-D67C1BAADD7F

Q37279897-1E710E0A-847F-4E45-B7D4-CE339E19876E

Q37279897-5485D623-B33B-4C33-803A-AA619D4BC128

Q37279897-7E8B647D-5FC2-4B6A-BE6C-C277C22C0ED0

Q37279897-82AA53CF-46A6-4007-9954-B6A6376FAEFB

Q37279897-BF093166-47BC-4938-9F99-B694A3C13CC9

Q37279897-E378737C-1F08-49BD-A8B7-EDF2B964868A

P2860

Q37279897-36980282-30A8-4CA5-B778-C90F5988F757

Q37279897-38E9B8B0-CCBE-4F3F-94E9-DC205D80E5FA

Q37279897-3C21CF45-CD9A-4403-BD2E-536008890F11

Q37279897-59273A59-E267-4FB3-88C4-844A8412FAC8

Q37279897-5F97BAA8-ABA4-497A-AA09-EF284FFDC20D

Q37279897-6206D5A7-3042-4106-8249-9D1BFB81697E

Q37279897-72821609-C759-426E-A751-4A321EBB3E0A

Q37279897-76C4E034-344F-4044-97F8-44E4EEA79C28

Q37279897-7D717090-7971-4273-814D-1067B44EB5A4

Q37279897-816958D5-C975-47BD-82AE-C7B92204BDB9

P304

Q37279897-A7FC1D6A-03A6-4918-BDDE-66A9B40B84CD

P31

Q37279897-8379828F-ECED-45D8-95FE-6A2A32A9AD08

P356

Q37279897-43D7234A-5AE5-4B78-9DB6-D5209434E980

P433

Q37279897-93935E0B-9C74-45C1-86B9-2B5CB1AB0A0B

P478

Q37279897-0BBE63DA-FDFB-43C1-9C17-0F51ECFCF402

P577

Q37279897-FDD1F82E-7E6B-480E-9C19-BB1BF4FB226C

P698

Q37279897-CEF31248-90AE-4A64-97C4-8617D078D4DB

P921

Q37279897-813C7420-A548-45D2-9733-7D3792D56803

P932

Q37279897-70593E09-4DA5-4024-A7B3-93558F95E4D8

P356

MSM.2016.28.303-306

P1433

Materia socio-medica

P1476

HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.

@en

P2093

Amra Iljazovic

http://www.w3.org/2001/XMLSchema#string

Denisa Salihovic Hajdarevic

http://www.w3.org/2001/XMLSchema#string

Dzevdet Smajlovic

http://www.w3.org/2001/XMLSchema#string

Omer C Ibrahimagic

http://www.w3.org/2001/XMLSchema#string

Suljo Kunic

http://www.w3.org/2001/XMLSchema#string

Zejneba Pasic

http://www.w3.org/2001/XMLSchema#string

Zikrija Dostovic

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders.

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).

Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients.

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease.

Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan.

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.

P304

303-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5455/MSM.2016.28.303-306

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698607

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5034996

http://www.w3.org/2001/XMLSchema#string